FIELD: ophthalmology.
SUBSTANCE: invention relates to ophthalmology and is intended for the early diagnosis of familial exudative vitreoretinopathy. In the lacrimal fluid of the diseased eye, the concentration of endothelin-1 is determined. If its value is over 8.0 pg/ml, familial exudative vitreoretinopathy is diagnosed.
EFFECT: invention provides adequate timely treatment with reduced incidence of severe stages and complications.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PERIPHERAL RETINAL HAEMANGIOBLASTOMA AND REACTIVE ASTROCYTIC RETINAL TUMOR | 2020 |
|
RU2733578C1 |
| METHOD OF ASSESSING INFLAMMATORY PROCESS IN CHILDREN WITH ENDOGENOUS UVEITIS | 2023 |
|
RU2805940C1 |
| METHOD FOR DETERMINING INDICATIONS FOR ACTIVE ANTI-INFLAMMATORY THERAPY BEFORE PERFORMING OPTO-RECONSTRUCTIVE OPERATIONS IN CHILDREN WITH ENDOGENOUS UVEITIS | 2022 |
|
RU2782132C1 |
| METHOD FOR PREDICTION OF DEVELOPING OR PROGRESSING PROLIFERATIVE SYNDROME IN ENDOGENOUS UVEITIS IN CHILDREN | 2015 |
|
RU2584246C1 |
| METHOD FOR EARLY DIAGNOSIS AND PREDICTION OF MACULAR EDEMA IN DIABETIC RETINOPATHY | 2020 |
|
RU2741693C1 |
| METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF MELANOMA OF THE CHOROID OF THE CENTRAL LOCALIZATION AND THE LATE STAGE OF AGE-RELATED MACULAR DEGENERATION | 2022 |
|
RU2792554C1 |
| METHOD FOR THE TREATMENT OF PROLIFERATIVE PROCESSES OF THE POSTERIOR SEGMENT OF THE EYE | 2018 |
|
RU2684927C1 |
| METHOD FOR DETERMINING INDICATIONS FOR ANTIANGIOGENIC THERAPY IN CASE OF SUSPICION OF WET FORM OF AGE-RELATED MACULAR DEGENERATION | 2021 |
|
RU2758662C1 |
| DIAGNOSTIC TECHNIQUE FOR ANGIOGRAPHICALLY AVASCULAR INITIAL CHOROID MELANOMA | 2010 |
|
RU2440070C1 |
| METHOD FOR PREDICTING AN UNFAVORABLE COURSE OF RETINOPATHY IN PREMATURE INFANTS | 2021 |
|
RU2761268C1 |
